We use cookies to personalise content, to provide features and to analyse our traffic. More informations...
Necessary
Analytics
Covir
Healthcare

Covir

Healthcare

Covir is the exclusive partner of Octopus Robots for the funding of robotic disinfection systems international licences based on tezos blockchain.

Presale ends in 16 days
01 Jun 2020 - 31 Jul 2020
Sale starts in 17 days
01 Aug 2020 - 31 Dec 2020
ICO Details
Hardcap:
24,000,000 USD
Softcap:
300,000 USD
Token Price:
0.2 USD
Total Supply:
400,000,000
ICO Supply:
120,000,000 (30%)
Accepting:
BTC, ETH, XTZ, TRX, USD
Whitelist/KYC:
KYC
Country:
Switzerland
Token Details
Token Platform:
Tezos
Coin Details
Ticker:
CVR
Share This Page
ICO Token Calculator
Calculations are based on prices updated 19 seconds ago and a starting sale price fixed at:
1 CVR = 0.2 USD
To The Moon 🚀🌕
ROI Price Market Cap Sale Supply Fully Diluted Market Cap
x1 $0.2 $24,000,000 $80,000,000
x2 $0.4 $48,000,000 $160,000,000
x3 $0.6 $72,000,000 $240,000,000
x4 $0.8 $96,000,000 $320,000,000
x5 $1.00 $120,000,000 $400,000,000
x6 $1.20 $144,000,000 $480,000,000
x7 $1.40 $168,000,000 $560,000,000
x8 $1.60 $192,000,000 $640,000,000
x9 $1.80 $216,000,000 $720,000,000
x10 $2.00 $240,000,000 $800,000,000
x15 $3.00 $360,000,000 $1,200,000,000
x20 $4.00 $480,000,000 $1,600,000,000
x25 $5.00 $600,000,000 $2,000,000,000
x50 $10.00 $1,200,000,000 $4,000,000,000
x100 $20.00 $2,400,000,000 $8,000,000,000
x1000 $200.00 $24,000,000,000 $80,000,000,000

Octopus Robots

Octopus Robots is a French public limited company with a board of directors, active for 33 years. Located in Cholet, France, the company has always been specialized in high technologies (e.g. non-contact measuring systems). In 2012, it moved into the HealthCare sector by developing patented technologies in the area of High Level Disinfection (HLD) on various surfaces, with an innovative airborne disinfection system and sold it through a network of distributors worldwide.

Nowadays, Octopus Robots develops and markets mobile, autonomous, smart and modular robots for use in various industries such as agricultural business, defense and surveillance. It is an innovation dedicated for businesses with a unique patented technology (PCT).

Octopus Robots is an AgTech and a pioneer company in the field of Biosafety, which has been listed on the stock exchange since March 14, 2018 on the Euronext Paris Access compartment.


Covir

Covir is powered by Pagest.environnement SA registered in Geneva Switzerland, founded in 2000 and active since. It is involved in sustainable devlopment projects, environment , green energy and biosecurity.

CVR Benefits

In partnership with Covir, Octopus Robots launches the prefinancing of its global portfolio of potential licenses by tokenizing its licensing rights on the tezos blockchain. The digitalization of license fees, therefore of intangible assets, enabled by tokenization will allow better liquidity, mutualisation and greater openness of countries or geographic areas under negotiation. It will allow better efficiency enabled by technology, smart contracts which will automate the payment of royalties.


Octopus Biosafety

Octopus Biosafety robot is designed to decontaminate equipment and large buildings such as food storage facilities and food processing plants, airport terminals, shopping malls and any other public buildings. It is a mobile, intelligent, fully autonomous and modular robot. It recharges itself and can be operated 24/7.
Its unique atomization module delivers biocides in aerosolized form (ultramicroscopic particles) while getting away from temperature gradients and air flow issues that may negatively impact disinfection operation. It continuously maps indoor conditions and alert operators in case of anomalies detected.
Octopus Biosafety is equipped with advanced communication and navigation systems that facilitate optimal guidance and monitoring, on a par with autonomous vehicles. It is equipped with motors and wheels adapted to harsh environments. It is a concentrate of advanced technology in the service of health, safety and productivity.

  • Versatility
    Our Octopus robots are all equipped with a common multipurpose base. This base has the function of a command post. Inside is all the intelligence necessary to easily control the robots. It was conceived to allow the application modules to be exchanged according to your needs.
  • Intelligence
    Our guidance technology is inspired of autonomous vehicles. Our concept is similar. All of our robots are equipped with advanced guidance and communication systems. They do not require human assistance during operations.
  • Mobility
    Our Octopus robots are fully mobile and automated. They can be equipped with pneumatic tires for harsh environment or « Mecanum » wheels which allow transverse displacement in narrow spaces. Our robots have been designed for indoor or outdoor use. Mobility & maneuverability are paramount as they allow for complete treatment of very large volumes.
  • Performance
    Our biosecurity robots outperform all competing solutions consisting of fixed installations or static equipment, even those that are supposedly mobile. Our robots circulate throughout the space to be treated and spread the disinfectant product uniformly on all surfaces. They decontaminate very large volumes by avoiding restrictions on distance, air flow and gradients (temperature, humidity) that can alter the effectiveness of disinfection. The disinfectant product is always distributed near the target areas.
  • Communication & Traceability
    A Wi-Fi interface provides real-time monitoring of the various operating parameters. Settings can be controlled remotely and operations log can be downloaded.
  • Autonomy
    Our robots move by themselves and are powered by a long-lasting battery. They automatically locate our OCTO-Ri-Charger station with which they associate to recharge with energy or active ingredients. Thus, our robots can be used 24/7 (There is no long / costly downtime. No service disruption).
  • Security
    Our Octopus robots guarantee a maximum level of performance and safety (no human intervention is required). They can be used by a large number of operators without any particular qualification.

Olivier Somville
Founder & CEO
Involved in 1 project
Marie Somville
Marketing & Communications Latin America
Involved in 1 project
Bertrand Vergne
CEO
Involved in 1 project
William Baude
CTO
Involved in 1 project
Jacques Point
CFO & STO Expert
Involved in 1 project
Jerome Leboeuf
Director R&D Software/Hardware
Involved in 1 project
Zied Chaabane
Arabic Manager & Project Manager
Involved in 3 projects
Vu Viet Anh
Vietnam Manager
Involved in 1 project
Sergei Lesnikov
CMO, Marketing Manager
Involved in 1 project
Peter Cris Nabida
Marketing Consultant
Involved in 1 project
  • 1987

    Foundation of the company. Initially, the company was specializing in developing and manufacturing metrology products for industrial applications.

  • 2004

    The company was taken over by Mr. Olivier Somville who brought a new dynamic and opened up new markets.

    MCAI took every opportunities and moved into various sectors such as HealthCare by developing patented technologies in the area of High Level Disinfection (HLD) for surfaces.

  • 2012

    MCAI has decided to massively invest in the development of innovative robots and hired a team of specialists. Since then, the company is exclusively devoted to develop its range of Octopus robots.

    In 2012, our Company moved into the HealthCare sector by developing patented technologies in the area of High Level Disinfection (HLD) for surfaces. It developed an innovative airborne disinfection system and sold it through a network of distributors worldwide.

  • 2014

    In 2014, our company moved into robotics completely. The “Octopus program” came alive.

  • 2016

    The company was awarded the INNOV’SPACE’s Trophy for its Octopus Poultry Safe robot

  • 2017

    Since June 2017 MCAI SAS becomes OCTOPUS ROBOTS SA

  • 2020

    Covir powered by Octopus Robots for the financing of international licenses for robotic disinfection systems based on the Tezos blockchain.

  • Q2 2020

    Private-Sale

    Marketing

    Recruitment

    Referral System Integration

    Wallet

  • Q3 2020

    Media Partnerships

    Platform Web Covir 2.0

    Website Translated to over 10 languages

    Tezos Collaboration

    At the end of the third quarter, our investors will receive their first royalties.

  • Q4 2020

    Launch of an IEO on a reputable exchange

    Marketing Campaign

    IEO bonus for Tezos holders

    Ambassador Program

  • 2021

    Implementation of Voting System

    Perspectives

    TV interviews

Loading...
 

Healthcare

Covir

Covir is the exclusive partner of Octopus Robots for the funding of robotic disinfection systems international licences based on tezos blockchain.

Presale ends in 16 days
01 Jun 2020 - 31 Jul 2020
Sale starts in 17 days
01 Aug 2020 - 31 Dec 2020
ICO Token Calculator
Calculations are based on prices updated 19 seconds ago and a starting sale price fixed at:
1 CVR = 0.2 USD
To The Moon 🚀🌕
ROI Price Market Cap Sale Supply Fully Diluted Market Cap
x1 $0.2 $24,000,000 $80,000,000
x2 $0.4 $48,000,000 $160,000,000
x3 $0.6 $72,000,000 $240,000,000
x4 $0.8 $96,000,000 $320,000,000
x5 $1.00 $120,000,000 $400,000,000
x6 $1.20 $144,000,000 $480,000,000
x7 $1.40 $168,000,000 $560,000,000
x8 $1.60 $192,000,000 $640,000,000
x9 $1.80 $216,000,000 $720,000,000
x10 $2.00 $240,000,000 $800,000,000
x15 $3.00 $360,000,000 $1,200,000,000
x20 $4.00 $480,000,000 $1,600,000,000
x25 $5.00 $600,000,000 $2,000,000,000
x50 $10.00 $1,200,000,000 $4,000,000,000
x100 $20.00 $2,400,000,000 $8,000,000,000
x1000 $200.00 $24,000,000,000 $80,000,000,000
ICO Details
Hardcap:
24,000,000 USD
Softcap:
300,000 USD
Token Price:
0.2 USD
Total Supply:
400,000,000
ICO Supply:
120,000,000 (30%)
Accepting:
BTC, ETH, XTZ, TRX, USD
Whitelist/KYC:
KYC
Country:
Switzerland
Token Details
Token Platform:
Tezos
Coin Details
Ticker:
CVR

Octopus Robots

Octopus Robots is a French public limited company with a board of directors, active for 33 years. Located in Cholet, France, the company has always been specialized in high technologies (e.g. non-contact measuring systems). In 2012, it moved into the HealthCare sector by developing patented technologies in the area of High Level Disinfection (HLD) on various surfaces, with an innovative airborne disinfection system and sold it through a network of distributors worldwide.

Nowadays, Octopus Robots develops and markets mobile, autonomous, smart and modular robots for use in various industries such as agricultural business, defense and surveillance. It is an innovation dedicated for businesses with a unique patented technology (PCT).

Octopus Robots is an AgTech and a pioneer company in the field of Biosafety, which has been listed on the stock exchange since March 14, 2018 on the Euronext Paris Access compartment.


Covir

Covir is powered by Pagest.environnement SA registered in Geneva Switzerland, founded in 2000 and active since. It is involved in sustainable devlopment projects, environment , green energy and biosecurity.

CVR Benefits

In partnership with Covir, Octopus Robots launches the prefinancing of its global portfolio of potential licenses by tokenizing its licensing rights on the tezos blockchain. The digitalization of license fees, therefore of intangible assets, enabled by tokenization will allow better liquidity, mutualisation and greater openness of countries or geographic areas under negotiation. It will allow better efficiency enabled by technology, smart contracts which will automate the payment of royalties.


Octopus Biosafety

Octopus Biosafety robot is designed to decontaminate equipment and large buildings such as food storage facilities and food processing plants, airport terminals, shopping malls and any other public buildings. It is a mobile, intelligent, fully autonomous and modular robot. It recharges itself and can be operated 24/7.
Its unique atomization module delivers biocides in aerosolized form (ultramicroscopic particles) while getting away from temperature gradients and air flow issues that may negatively impact disinfection operation. It continuously maps indoor conditions and alert operators in case of anomalies detected.
Octopus Biosafety is equipped with advanced communication and navigation systems that facilitate optimal guidance and monitoring, on a par with autonomous vehicles. It is equipped with motors and wheels adapted to harsh environments. It is a concentrate of advanced technology in the service of health, safety and productivity.

  • Versatility
    Our Octopus robots are all equipped with a common multipurpose base. This base has the function of a command post. Inside is all the intelligence necessary to easily control the robots. It was conceived to allow the application modules to be exchanged according to your needs.
  • Intelligence
    Our guidance technology is inspired of autonomous vehicles. Our concept is similar. All of our robots are equipped with advanced guidance and communication systems. They do not require human assistance during operations.
  • Mobility
    Our Octopus robots are fully mobile and automated. They can be equipped with pneumatic tires for harsh environment or « Mecanum » wheels which allow transverse displacement in narrow spaces. Our robots have been designed for indoor or outdoor use. Mobility & maneuverability are paramount as they allow for complete treatment of very large volumes.
  • Performance
    Our biosecurity robots outperform all competing solutions consisting of fixed installations or static equipment, even those that are supposedly mobile. Our robots circulate throughout the space to be treated and spread the disinfectant product uniformly on all surfaces. They decontaminate very large volumes by avoiding restrictions on distance, air flow and gradients (temperature, humidity) that can alter the effectiveness of disinfection. The disinfectant product is always distributed near the target areas.
  • Communication & Traceability
    A Wi-Fi interface provides real-time monitoring of the various operating parameters. Settings can be controlled remotely and operations log can be downloaded.
  • Autonomy
    Our robots move by themselves and are powered by a long-lasting battery. They automatically locate our OCTO-Ri-Charger station with which they associate to recharge with energy or active ingredients. Thus, our robots can be used 24/7 (There is no long / costly downtime. No service disruption).
  • Security
    Our Octopus robots guarantee a maximum level of performance and safety (no human intervention is required). They can be used by a large number of operators without any particular qualification.

Share This Page
Olivier Somville
Founder & CEO
Involved in 1 project
Marie Somville
Marketing & Communications Latin America
Involved in 1 project
Bertrand Vergne
CEO
Involved in 1 project
William Baude
CTO
Involved in 1 project
Jacques Point
CFO & STO Expert
Involved in 1 project
Jerome Leboeuf
Director R&D Software/Hardware
Involved in 1 project
Zied Chaabane
Arabic Manager & Project Manager
Involved in 3 projects
Vu Viet Anh
Vietnam Manager
Involved in 1 project
Sergei Lesnikov
CMO, Marketing Manager
Involved in 1 project
Peter Cris Nabida
Marketing Consultant
Involved in 1 project
  • 1987

    Foundation of the company. Initially, the company was specializing in developing and manufacturing metrology products for industrial applications.

  • 2004

    The company was taken over by Mr. Olivier Somville who brought a new dynamic and opened up new markets.

    MCAI took every opportunities and moved into various sectors such as HealthCare by developing patented technologies in the area of High Level Disinfection (HLD) for surfaces.

  • 2012

    MCAI has decided to massively invest in the development of innovative robots and hired a team of specialists. Since then, the company is exclusively devoted to develop its range of Octopus robots.

    In 2012, our Company moved into the HealthCare sector by developing patented technologies in the area of High Level Disinfection (HLD) for surfaces. It developed an innovative airborne disinfection system and sold it through a network of distributors worldwide.

  • 2014

    In 2014, our company moved into robotics completely. The “Octopus program” came alive.

  • 2016

    The company was awarded the INNOV’SPACE’s Trophy for its Octopus Poultry Safe robot

  • 2017

    Since June 2017 MCAI SAS becomes OCTOPUS ROBOTS SA

  • 2020

    Covir powered by Octopus Robots for the financing of international licenses for robotic disinfection systems based on the Tezos blockchain.

  • Q2 2020

    Private-Sale

    Marketing

    Recruitment

    Referral System Integration

    Wallet

  • Q3 2020

    Media Partnerships

    Platform Web Covir 2.0

    Website Translated to over 10 languages

    Tezos Collaboration

    At the end of the third quarter, our investors will receive their first royalties.

  • Q4 2020

    Launch of an IEO on a reputable exchange

    Marketing Campaign

    IEO bonus for Tezos holders

    Ambassador Program

  • 2021

    Implementation of Voting System

    Perspectives

    TV interviews

Loading...

Other Healthcare Projects
IEO
Sale ends in 28 days
12 Jul 2020
Active
12 Aug 2020
IEO
Sale ended 22 Jan 2020
24 Oct 2019
Ended
22 Jan 2020
IEO
Sale ended 18 Oct 2019
16 Oct 2019
Ended
18 Oct 2019
Trading
IEO
Sale ended 26 Jul 2019
24 Jun 2019
Ended
26 Jul 2019
IEO
Sale ended 16 May 2019
16 May 2019
Ended
16 May 2019
Trading
ICO
Sale ended 28 Feb 2018
17 Feb 2018
Ended
28 Feb 2018
This website and the information contained herein is not intended to be a source of advice or credit analysis with respect to the material presented, and the information and/or documents contained in this website do not constitute investment advice.